Literature DB >> 6347229

A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.

C A Morley, C Cavalcanti, E J Perrins, R Sutton.   

Abstract

Atenolol 100 mg once daily and metoprolol SA 200 mg once daily were compared in 20 patients with mild to moderate hypertension, in a randomised, double-blind cross-over trial. Blood pressure and heart rate were compared at rest and during maximal exercise on a bicycle ergometer at 2 and 24 h post-dose. Blood pressure control was similar with both drugs, except at 2 h when systolic blood pressure was significantly lower with atenolol. Blood pressure and heart rate were less well controlled at 24 h than at 2 h with both drugs, but the majority of patients were still considered adequately controlled at 24 h. Atenolol and metoprolol SA can be considered equally effective in the treatment of mild to moderate hypertension and can be recommended as a once daily regime.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347229      PMCID: PMC1427914          DOI: 10.1111/j.1365-2125.1983.tb01555.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Clinical pharmacokinetics of atenolol.

Authors:  J McAinsh
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

2.  Dosing intervals in beta-blocker therapy.

Authors:  M B Comerford; E Besterman
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

3.  Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.

Authors:  G Johnsson; L Jordö; P Lundborg; C G Regårdh; O Rönn
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-07

4.  Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.

Authors:  R G Wilcox; J R Hampton
Journal:  Br Heart J       Date:  1981-11

5.  Atenolol and metoprolol once daily in hypertension.

Authors:  A K Scott; J W Rigby; J Webster; G M Hawksworth; J C Petrie; H G Lovell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-22

6.  Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.

Authors:  S Freestone; J H Silas; M S Lennard; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

  6 in total
  4 in total

Review 1.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 2.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

3.  Evidence based general practice: a retrospective study of interventions in one training practice.

Authors:  P Gill; A C Dowell; R D Neal; N Smith; P Heywood; A E Wilson
Journal:  BMJ       Date:  1996-03-30

Review 4.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.